hand-selected seven days a week sponsored by:

Another Breach of Employee Data at Pfizer
WSJ Online 5/13/08

AstraZeneca's Toprol Raises Risk of Death, Study Says
Bloomberg 5/13/08

Drug sales representatives may face new competition in hospital halls and doctor offices — from the federal government
Wilkes-Barre Times Leader, PA 5/13/08

GSK's Tykerb up against Herceptin in early breast cancer study
PharmaTimes, UK 5/13/08

Biotech: crunch time for UK biotech
Telegraph, UK 5/13/08

Schering-Plough May Settle for Less on Clotting Partnership
WSJ Online 5/13/08

ImClone Falls After Analyst Says Sell, Citing Data
Bloomberg 5/13/08

ImClone 'Eager' for Erbitux Data Release
TheStreet.com 5/13/08

Daiichi Sankyo forecasts surprise sharp profit fall
Forbes 5/13/08

FDA approves Novo Nordisk's clot therapy
Pharmaceutical Business Review 5/13/08

Analyst Upbeat on Allergan, Alcon, Cautious on Advanced Medical
Orange County Business Journal, CA 5/13/08

Merging Mylan Meanders Through 2008
Motley Fool 5/13/08

Myriad Options on Alzheimers Disease
Seeking Alpha 5/13/08

Generic Plavix opens door for API manufacturers
InPharma Technologist 5/13/08

NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
Genetic Engineering News 5/13/08

Six Significant Gene Therapy Stocks
SeekingAlpha 5/13/08

Novacea slashing work force in wake of failed drug
CNBC 5/13/08

Chinese drugs seen driving down generic prices
Reuters 5/13/08

Viagra may help heart in muscular dystrophy: study
Reuters 5/13/08

Eli Lilly to help train doctors on drug-resistant TB
Reuters 5/13/08

Barr Pharmaceuticals Get FDA Approval For Generic Contraceptive Amid Patent Dispute
Trading Markets, CA 5/13/08

Beta blockers before surgery raise risks: Study
Toronto Star, Canada 5/13/08

Valeant Announces Successful Completion of Retigabine Phase III Epilepsy Program Validating Novel Mechanism of Action
Trading Markets, CA 5/13/08

miss yesterday's headlines? check our archives

want these headlines on your site or company intranet?